Selective PGHS-2 Inhibitors: A Rational Approach for Treatment of the Inflammation

Author(s): C. R. Rodrigues, M. P. Veloso, H. Verli, C. A.M. Fraga, A. L.P. Miranda, E. J. Barreiro

Journal Name: Medicinal Chemistry Reviews - Online (Discontinued)

Volume 1 , Issue 1 , 2004


Prostaglandin-H synthase exists in two isoforms, PGHS-1 and PGHS-2. PGHS-1 is present and is constitutively expressed in most cells and tissues, whereas PGHS-2 is mainly thought to mediate inflammation. Selective prostaglandin-H synthase-2 (or cyclooxygenase-2) inhibitors have been shown to be potent antiinflammatory agents with fewer side effects than currently marketed nonsteroidal antiinflammatory drugs (NSAIDs). This review addresses the main classes of the selective PGHS-2 inhibitors whose selectivity is documented by supporting PGHS-1 and PGHS-2 enzyme data. In addition, we also describe our experience in design, synthesis and pharmacological in vivo evaluation of new 1,2-benzodioxole derivatives as candidate of the selective PGHS-2 inhibitors, with special attention to molecular dynamics simulations of these derivatives attached to the active site of PGHS-2.

Keywords: nsaids, pghs-2 inhibitors, 3d-pharmacophore model, molecular dynamics

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2004
Page: [73 - 90]
Pages: 18
DOI: 10.2174/1567203043480485

Article Metrics

PDF: 9